R N Fedorak1. Show Affiliations » 1. University of Alberta, Edmonton, Canada.
Abstract
Entities: Disease
Mesh: See more » Antibodies, Monoclonal/therapeutic useCrohn Disease/drug therapyGastrointestinal Agents/therapeutic useHumansInfliximab
Substances: See more » Antibodies, MonoclonalGastrointestinal AgentsInfliximab
Year: 2001 PMID: 11429665 DOI: 10.1155/2001/194506
Source DB: PubMed Journal: Can J Gastroenterol ISSN: 0835-7900 Impact factor: 3.522